Minimal Clinically Important Differences for the Modified Rodnan Skin Score: Results from the Scleroderma Lung Studies (SLS-I and SLS-II)

Minimal Clinically Important Differences for the Modified Rodnan Skin Score: Results from the Scleroderma Lung Studies (SLS-I and SLS-II)

Abstract Objective This study aimed to assess the minimal clinically important differences (MCIDs) for the modified Rodnan skin score (mRSS) using combined data from the Scleroderma Lung Studies (I and II). Methods MCID estimates for the mRSS at 12 months were calculated using three anchors: change...

Full description

Bibliographic Details
Main Authors: Dinesh Khanna, Philip J. Clements, Elizabeth R. Volkmann, Holly Wilhalme, Chi-hong Tseng, Daniel E. Furst, Michael D. Roth, Oliver Distler, Donald P. Tashkin
Format: Article
Language:English
Published: BMC 2019-01-01
Series:Arthritis Research & Therapy
Subjects:
Interstitial lung disease
Systemic sclerosis
Minimal clinically important difference
Skin thickness
Scleroderma
Modified Rodnan skin score
Online Access:http://link.springer.com/article/10.1186/s13075-019-1809-y

Internet

http://link.springer.com/article/10.1186/s13075-019-1809-y

Similar Items